These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6180542

  • 1. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ, Williams JJ.
    Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
    [No Abstract] [Full Text] [Related]

  • 2. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
    van der Gaast A, Hoekstra JW, Croles JJ, Splinter TA.
    J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
    [Abstract] [Full Text] [Related]

  • 3. [Progress in the therapy of testicular teratoid tumors].
    Seeber S.
    Wien Med Wochenschr; 1982 Jul 31; 132(13-14):329-33. PubMed ID: 6182701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
    Horwich A, Peckham MJ.
    Eur J Cancer Clin Oncol; 1984 Dec 31; 20(12):1463-70. PubMed ID: 6209145
    [Abstract] [Full Text] [Related]

  • 6. Benign intracranial hypertension during chemotherapy for testicular teratoma.
    Marsh LF, Morgan DA, Jefferson D.
    Br J Radiol; 1988 Aug 31; 61(728):692. PubMed ID: 2458158
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
    Fossa SD, Paus E.
    Prog Clin Biol Res; 1985 Aug 31; 203():121. PubMed ID: 2421325
    [No Abstract] [Full Text] [Related]

  • 9. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
    Hayashi M, Ebihara K, Urano E.
    Gan To Kagaku Ryoho; 1984 Dec 31; 11(12 Pt 2):2775-7. PubMed ID: 6210063
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy of disseminated seminoma.
    Einhorn LH, Williams SD.
    Cancer Clin Trials; 1980 Dec 31; 3(4):307-13. PubMed ID: 6159120
    [Abstract] [Full Text] [Related]

  • 11. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG, Scardino PT.
    Trans Am Assoc Genitourin Surg; 1979 Dec 31; 71():31-5. PubMed ID: 94715
    [No Abstract] [Full Text] [Related]

  • 12. Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.
    Horwich A, Peckham MJ.
    Cancer Treat Rep; 1986 Nov 31; 70(11):1329-31. PubMed ID: 2429765
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ, Norman AR, Dearnaley DP, Horwich A.
    J Clin Oncol; 1995 Jan 31; 13(1):87-92. PubMed ID: 7528272
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
    Behrendt H, Ringert RH, Pfeiffer R, Homann W, Hartung R.
    Urol Int; 1983 Jan 31; 38(5):307-9. PubMed ID: 6195793
    [Abstract] [Full Text] [Related]

  • 17. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
    Mead GM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM, Buchanan R.
    Cancer Treat Rep; 1983 Apr 31; 67(4):410. PubMed ID: 6189603
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased.
    Tonkin KS, Rustin GJ, Wignall B, Paradinas F, Bennett M.
    Eur J Cancer Clin Oncol; 1989 Dec 31; 25(12):1739-43. PubMed ID: 2483686
    [Abstract] [Full Text] [Related]

  • 20. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
    Vogelzang NJ, Lange PH, Goldman A, Vessela RH, Fraley EE, Kennedy BJ.
    Cancer Res; 1982 Nov 31; 42(11):4855-61. PubMed ID: 6181870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.